Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers

Viruses. 2023 Apr 13;15(4):955. doi: 10.3390/v15040955.

Abstract

Background: The nucleocapsid protein of SARS-CoV-2 participates in viral replication, transcription, and assembly. Antibodies against this protein have been proposed for the epidemiological analysis of the seroprevalence of COVID-19 associated with natural infection by SARS-CoV-2. Health workers were one of the most exposed populations, and some had an asymptomatic form of the disease, so detecting IgG antibodies and subclasses against the N protein can help to reclassify their epidemiological status and obtain information about the effector mechanisms associated with viral elimination.

Methods: In this study, we analyzed 253 serum samples collected in 2021 and derived from health workers, and evaluated the presence of total IgG and subclasses against the N protein of SARS-CoV-2 by indirect ELISA.

Results: From the analyzed samples, 42.69% were positive to anti-N IgG antibodies. A correlation between COVID-19 asymptomatic infection and IgG antibodies was observed (p = 0.006). The detected subclasses were: IgG1 (82.4%), IgG2 (75.9%), IgG3 (42.6%), and IgG4 (72.6%).

Conclusions: This work provides evidence about the high seroprevalence of total IgG and subclasses of anti-N and their relations with the asymptomatic infection of SARS-CoV-2 and related symptoms.

Keywords: COVID-19; IgG; N protein; SARS-CoV-2; antibodies; health workers.

MeSH terms

  • Antibodies, Viral
  • Asymptomatic Infections
  • COVID-19* / epidemiology
  • Humans
  • Immunoglobulin G
  • Nucleocapsid
  • SARS-CoV-2*
  • Seroepidemiologic Studies

Substances

  • Immunoglobulin G
  • Antibodies, Viral

Grants and funding

This research received no external funding.